Newsroom | 7395 results

VANCOUVER, British Columbia--(BUSINESS WIRE)--ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”) (CSE: METX) (FSE: Q9T), a publicly listed biotechnology company working on novel cancer-fighting drugs in the field of immuno-oncology, today announced an extension to its option agreement to license the National Research Council of Canada’s (NRC) proprietary nanobody-based CD22 binder for use in Chimeric Antigen Receptor (CAR) therapy. ME Therapeutics will continue developing the CD...

TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices held a ceremony to celebrate the recognition of the 1983 commercialization of thin-film Hall elements as an IEEE Milestone....

EWING, N.J.--(BUSINESS WIRE)--UDC announced its results for the third quarter, ended September 30, 2026, will be released on Wednesday, October 28, 2026....

LEMONT, Ill.--(BUSINESS WIRE)--Argonne and collaborators will use super intelligence (SI) to speed discovery in software, materials, physics and more...

FREMONT, Calif., & CLEARWATER, Fla.--(BUSINESS WIRE)--TD SYNNEX (NYSE: SNX) shared the next evolution of PartnerFirst for North American partners, introducing new agentic AI capabilities....

SAN JOSE, Calif.--(BUSINESS WIRE)--Kioxia will be at the Open Compute Project (OCP) Global Summit next week....

VANCOUVER, British Columbia--(BUSINESS WIRE)--Nano One® Materials Corp. (“Nano One” or the “Company”) (TSX: NANO) (OTCQB: NNOMF) (Frankfurt: LBMB), a process technology company specializing in cathode active materials (CAM) for lithium-ion batteries, is pleased to announce a key milestone in its feedstock qualification program. A diverse range of lithium carbonate and phosphoric acid suppliers have now been pre-qualified for LFP cathode production, with suppliers of iron oxide also advancing th...

PETALUMA, Calif.--(BUSINESS WIRE)--Diamond Quanta Inc., which is building manufacturing infrastructure to standardize semiconductor-compatible engineered diamond integration, today announced that it has established Diamond Valley, its new operations and process development center in Petaluma, California, and begun preparing the site for Diamond Forge 1, the company’s planned pilot manufacturing and process integration environment. The Petaluma site will serve as Diamond Quanta’s primary Califor...

CHICAGO--(BUSINESS WIRE)--Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene (V940/mRNA-4157), a novel, potential first-in-class individualized neoantigen therapy (INT) being evaluated in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with completely resected stage IIB-IV melanoma and other cancer types. Intismeran autogene is jointly developed by Moderna and Merck, know...

WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation Inc. (NYSE: ONTO) (“Onto Innovation,” “Onto,” or the “Company”) today invites registration for its Company-sponsored analyst event on December 17, 2026 at the New York Stock Exchange, New York, New York. If you plan to attend in person, please RSVP by December 9 in order to gain access into the NYSE. Register for the event. Onto Innovation Analyst Event: Momentum Unleashed The professional investment community is invited to join Onto’s executi...